UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma

British journal of cancer, 2019-03, Vol.120 (5), p.512-521

2019

Volltextzugriff (PDF)

Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway

Cancer research (Chicago, Ill.), 2014-12, Vol.74 (23), p.6867-6877

2014

Volltextzugriff (PDF)

Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma

Nature medicine, 2016-09, Vol.22 (9), p.1056-1061

2016

Volltextzugriff (PDF)

Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior

Oncoimmunology, 2017-11, Vol.6 (11), p.e1358332-e1358332

2017

Volltextzugriff (PDF)

Phenformin Enhances the Efficacy of ERK Inhibition in NF1-Mutant Melanoma

Journal of investigative dermatology, 2017-05, Vol.137 (5), p.1135-1143

2017

Volltextzugriff (PDF)

Loss of AMPKα2 promotes melanoma tumor growth and brain metastasis

iScience, 2023-06, Vol.26 (6), p.106791-106791, Article 106791

2023

Volltextzugriff (PDF)

Addicted to AA (Acetoacetate): A Point of Convergence between Metabolism and BRAF Signaling

Molecular cell, 2015-08, Vol.59 (3), p.333-334

2015

Volltextzugriff (PDF)

Preclinical evaluation of 3-18F-fluoro-2,2-dimethylpropionic acid as an imaging agent for tumor detection

The Journal of nuclear medicine (1978), 2014-09, Vol.55 (9), p.1506-1512

2014

Volltextzugriff (PDF)

Phenformin Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma

Journal of investigative dermatology, 2017-08, Vol.137 (8), p.1740-1748

2017

Volltextzugriff (PDF)

Altered cytochrome 2E1 and 3A P450‐dependent drug metabolism in advanced ovarian cancer correlates to tumour‐associated inflammation

British journal of pharmacology, 2019-09, Vol.176 (18), p.3712-3722

2019

Volltextzugriff (PDF)

Abstract A68: Targeting metabolic vulnerabilities of MDSCs to enhance the antitumor activity of PD-1 blockade

Cancer immunology research, 2018-09, Vol.6 (9_Supplement), p.A68-A68

2018

Volltextzugriff (PDF)

Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer

Journal of clinical pathology, 2015-09, Vol.68 (9), p.703-709

2015

Volltextzugriff (PDF)

Programmed cell death ligands expression in pheochromocytomas (PCC) and paragangliomas (PGL): Relationship with the hypoxic response and malignant behaviour

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.11597-11597

2017

Volltextzugriff (PDF)

Pharmacological inhibition of Axl tyrosine kinase as a novel therapeutic strategy in hepatocellular carcinoma

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15152-e15152

2015

Volltextzugriff (PDF)

Development and Evaluation of an 18F‑Radiolabeled Monocyclam Derivative for Imaging CXCR4 Expression

Molecular pharmaceutics, 2019-05, Vol.16 (5), p.2106-2117

2019

Volltextzugriff (PDF)

Development and Evaluation of an 18 F-Radiolabeled Monocyclam Derivative for Imaging CXCR4 Expression

Molecular pharmaceutics, 2019-05, Vol.16 (5), p.2106-2117

2019

Volltextzugriff (PDF)

The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth

Oncotarget, 2016-06, Vol.7 (24), p.37103-37120

2016

Volltextzugriff (PDF)

Positron Emission Tomography Imaging with 18F-Labeled Z HER2:2891 Affibody for Detection of HER2 Expression and Pharmacodynamic Response to HER2-Modulating Therapies

Clinical cancer research, 2014-03, Vol.20 (6), p.1632-1643

2014

Volltextzugriff (PDF)

Positron Emission Tomography Imaging with 18F-Labeled ZHER2:2891 Affibody for Detection of HER2 Expression and Pharmacodynamic Response to HER2-Modulating Therapies

Clinical cancer research, 2014-03, Vol.20 (6), p.1632-1643

2014

Volltextzugriff (PDF)

Preclinical Evaluation of 3- super(18)F- Fluoro-2,2-Dimethylpropionic Acid as an Imaging Agent for Tumor Detection

The Journal of nuclear medicine (1978), 2014-09, Vol.55 (9), p.1506-1506

2014

Volltextzugriff (PDF)

Preclinical Evaluation of 3- 18 F-Fluoro-2,2-Dimethylpropionic Acid as an Imaging Agent for Tumor Detection

Journal of Nuclear Medicine, 2014-09, Vol.55 (9), p.1506-1512

2014

Volltextzugriff (PDF)

Preclinical Evaluation of 3-^sup 18^F-Fluoro-2,2-Dimethylpropionic Acid as an Imaging Agent for Tumor Detection

The Journal of nuclear medicine (1978), 2014-09, Vol.55 (9), p.1506

2014

Volltextzugriff (PDF)

Abstract B140: Positron emission tomography imaging of HER2 expression and pharmacodynamic response to HSP90 inhibition with the next-generation ZHER2:2891 Affibody molecule [18F]GE-226

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.B140-B140

2013

Volltextzugriff (PDF)

Abstract C118: Choline kinase inhibition with the novel pharmacological inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth

Molecular cancer therapeutics, 2015-12, Vol.14 (12_Supplement_2), p.C118-C118

2015

Volltextzugriff (PDF)

Choline kinase inhibition as a treatment strategy of cancers with deregulated lipid metabolism

Trousil, Sebastian

2014

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(27)
Dissertationen
(1)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma

Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway

Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma

Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior

Phenformin Enhances the Efficacy of ERK Inhibition in NF1-Mutant Melanoma

Loss of AMPKα2 promotes melanoma tumor growth and brain metastasis

Addicted to AA (Acetoacetate): A Point of Convergence between Metabolism and BRAF Signaling

Preclinical evaluation of 3-18F-fluoro-2,2-dimethylpropionic acid as an imaging agent for tumor detection

Phenformin Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma

Altered cytochrome 2E1 and 3A P450‐dependent drug metabolism in advanced ovarian cancer correlates to tumour‐associated inflammation

Abstract A68: Targeting metabolic vulnerabilities of MDSCs to enhance the antitumor activity of PD-1 blockade

Exploiting altered patterns of choline kinase-alpha expression on human prostate tissue to prognosticate prostate cancer

Programmed cell death ligands expression in pheochromocytomas (PCC) and paragangliomas (PGL): Relationship with the hypoxic response and malignant behaviour

Pharmacological inhibition of Axl tyrosine kinase as a novel therapeutic strategy in hepatocellular carcinoma

Development and Evaluation of an 18F‑Radiolabeled Monocyclam Derivative for Imaging CXCR4 Expression

Development and Evaluation of an 18 F-Radiolabeled Monocyclam Derivative for Imaging CXCR4 Expression

The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth

Positron Emission Tomography Imaging with 18F-Labeled Z HER2:2891 Affibody for Detection of HER2 Expression and Pharmacodynamic Response to HER2-Modulating Therapies

Positron Emission Tomography Imaging with 18F-Labeled ZHER2:2891 Affibody for Detection of HER2 Expression and Pharmacodynamic Response to HER2-Modulating Therapies

Preclinical Evaluation of 3- super(18)F- Fluoro-2,2-Dimethylpropionic Acid as an Imaging Agent for Tumor Detection

Preclinical Evaluation of 3- 18 F-Fluoro-2,2-Dimethylpropionic Acid as an Imaging Agent for Tumor Detection

Preclinical Evaluation of 3-^sup 18^F-Fluoro-2,2-Dimethylpropionic Acid as an Imaging Agent for Tumor Detection

Abstract B140: Positron emission tomography imaging of HER2 expression and pharmacodynamic response to HSP90 inhibition with the next-generation ZHER2:2891 Affibody molecule [18F]GE-226

Abstract C118: Choline kinase inhibition with the novel pharmacological inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth

Choline kinase inhibition as a treatment strategy of cancers with deregulated lipid metabolism

Suchergebnisse filtern